
Magdalena Wygralak
GSK (NYSE:GSK) announced Thursday that the U.S. Food and Drug Administration (FDA) approved a new prefilled syringe presentation of its shingles vaccine, Shingrix, offering a convenient administration option for healthcare workers.
The current version of the vaccine comprises two vials—one